Literature DB >> 8041731

A kinase-negative epidermal growth factor receptor that retains the capacity to stimulate DNA synthesis.

K J Coker1, J V Staros, C A Guyer.   

Abstract

The residue proposed to serve as the catalytic base for phosphoryl transfer, Asp-813, of the human epidermal growth factor receptor (EGFR) was mutated to Ala, and the mutant receptor (D813A) was expressed in Chinese hamster ovary (CHO) cells. Partially purified D813A exhibited no detectable kinase activity in the absence or presence of EGF. A low level of EGF-stimulable phosphorylation of D813A was detectable in intact cells, apparently due to the activity of an associated Tyr kinase(s). As previously observed for kinase-inactive Lys-721 mutants, EGF binding to D813A stimulates mitogen-activated protein kinase activity. Surprisingly, and unlike results reported for Lys-721 mutants, D813A is capable of stimulating both 86Rb+ uptake and DNA synthesis in response to EGF. These data suggest not only that Asp-813 is critical to the catalytic activity of the EGFR but also that differences may exist in the signaling properties of kinase-negative Lys-721 and kinase-negative Asp-813 EGFR mutants.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041731      PMCID: PMC44319          DOI: 10.1073/pnas.91.15.6967

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Identification of residues in the nucleotide binding site of the epidermal growth factor receptor/kinase.

Authors:  M W Russo; T J Lukas; S Cohen; J V Staros
Journal:  J Biol Chem       Date:  1985-05-10       Impact factor: 5.157

2.  Mutational analysis of a phosphotransfer motif essential for v-fps tyrosine kinase activity.

Authors:  M F Moran; C A Koch; I Sadowski; T Pawson
Journal:  Oncogene       Date:  1988-12       Impact factor: 9.867

3.  Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization.

Authors:  C R Savage; S Cohen
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Deletion of exon 21 of the insulin receptor eliminates tyrosine kinase activity but preserves mitogenic signaling.

Authors:  G C Rolband; J F Williams; N J Webster; D Hsu; J M Olefsky
Journal:  Biochemistry       Date:  1993-12-14       Impact factor: 3.162

Review 6.  New insights into protein-tyrosine kinase receptor signaling complexes.

Authors:  M J Fry; G Panayotou; G W Booker; M D Waterfield
Journal:  Protein Sci       Date:  1993-11       Impact factor: 6.725

7.  Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor.

Authors:  D R Knighton; D L Cadena; J Zheng; L F Ten Eyck; S S Taylor; J M Sowadski; G N Gill
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

8.  Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells.

Authors:  E Livneh; R Prywes; O Kashles; N Reiss; I Sasson; Y Mory; A Ullrich; J Schlessinger
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

9.  Physiological inhibitors of the catalytic subunit of cAMP-dependent protein kinase: effect of MgATP on protein-protein interactions.

Authors:  F W Herberg; S S Taylor
Journal:  Biochemistry       Date:  1993-12-21       Impact factor: 3.162

10.  Epidermal growth factor stimulates a protein tyrosine kinase which is separable from the epidermal growth factor receptor.

Authors:  O Filhol; E M Chambaz; G N Gill; C Cochet
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

View more
  24 in total

1.  Nucleotide-binding properties of kinase-deficient epidermal-growth-factor-receptor mutants.

Authors:  K Cheng; J G Koland
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

Review 2.  Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.

Authors:  Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

3.  ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation.

Authors:  Fumin Shi; Shannon E Telesco; Yingting Liu; Ravi Radhakrishnan; Mark A Lemmon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

4.  Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein.

Authors:  S L Sierke; K Cheng; H H Kim; J G Koland
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

Review 5.  EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.

Authors:  Cristina Zahonero; Pilar Sánchez-Gómez
Journal:  Cell Mol Life Sci       Date:  2014-03-27       Impact factor: 9.261

6.  Computational delineation of tyrosyl-substrate recognition and catalytic landscapes by the epidermal growth factor receptor tyrosine kinase domain.

Authors:  Yingting Liu; Ravi Radhakrishnan
Journal:  Mol Biosyst       Date:  2014-04-29

7.  Survival of cancer cells is maintained by EGFR independent of its kinase activity.

Authors:  Zhang Weihua; Rachel Tsan; Wei-Chien Huang; Qiuyu Wu; Chao-Hua Chiu; Isaiah J Fidler; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

8.  A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.

Authors:  Jiannong Li; Uwe Rix; Bin Fang; Yun Bai; Arthur Edwards; Jacques Colinge; Keiryn L Bennett; Jingchun Gao; Lanxi Song; Steven Eschrich; Giulio Superti-Furga; John Koomen; Eric B Haura
Journal:  Nat Chem Biol       Date:  2010-02-28       Impact factor: 15.040

9.  Activation of c-fos gene expression by a kinase-deficient epidermal growth factor receptor.

Authors:  E R Eldredge; G M Korf; T A Christensen; D C Connolly; M J Getz; N J Maihle
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

10.  Tyrosine kinase activity may be necessary but is not sufficient for c-erbB1-mediated tissue-specific tumorigenicity.

Authors:  D C Connolly; S L Toutenhoofd; N J Maihle
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.